Cargando…
Eukaryotic elongation factor 2 kinase inhibitor, A484954 potentiates β-adrenergic receptor agonist-induced acute decrease in diastolic blood pressure in rats
Eukaryotic elongation factor 2 (eEF2) kinase (eEF2K) acts to inhibit protein translation through phosphorylating a specific substrate, eEF2. We previously found that the increased eEF2K expression in mesenteric artery mediates hypertension development in spontaneously hypertensive rats. More recentl...
Autores principales: | KODAMA, Tomoko, OKADA, Muneyoshi, YAMAWAKI, Hideyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Veterinary Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863711/ https://www.ncbi.nlm.nih.gov/pubmed/31484844 http://dx.doi.org/10.1292/jvms.19-0425 |
Ejemplares similares
-
Eukaryotic elongation factor 2 kinase inhibitor, A484954 inhibits noradrenaline-induced acute increase of blood pressure in rats
por: KODAMA, Tomoko, et al.
Publicado: (2018) -
Age-dependent increase in activity of eukaryotic elongation factor 2 kinase in mesenteric arteries from spontaneously hypertensive
rats
por: KODAMA, Tomoko, et al.
Publicado: (2020) -
Chemerin fragments show different effects on systemic blood pressure
dependent on carboxyl-terminal cleavage site
por: YAMAMOTO, Atsunori, et al.
Publicado: (2022) -
Autocrine role of senescent cardiac fibroblasts-derived extracellular vesicles
por: FUJIOKA, Yusei, et al.
Publicado: (2023) -
Coordination of changes in expression and phosphorylation of eukaryotic elongation factor 2 (eEF2) and eEF2 kinase in hypertrophied cardiomyocytes
por: Kameshima, Satoshi, et al.
Publicado: (2016)